Compare CanSino Biologics, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
HKD 4,439 Million ()
NA (Loss Making)
NA
0.00%
-0.28
-2.94%
0.82
Revenue and Profits:
Net Sales:
412 Million
(Quarterly Results - Dec 2025)
Net Profit:
15 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.49%
0%
-5.49%
6 Months
-36.83%
0%
-36.83%
1 Year
-5.73%
0%
-5.73%
2 Years
91.2%
0%
91.2%
3 Years
-21.33%
0%
-21.33%
4 Years
-73.67%
0%
-73.67%
5 Years
-89.56%
0%
-89.56%
CanSino Biologics, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
174.56%
EBIT Growth (5y)
-1.44%
EBIT to Interest (avg)
-60.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.09
Tax Ratio
1.16%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.84%
ROE (avg)
4.54%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.21
EV to EBIT
-15.78
EV to EBITDA
-42.01
EV to Capital Employed
1.29
EV to Sales
5.02
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.17%
ROE (Latest)
-3.37%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
411.70
339.00
21.45%
Operating Profit (PBDIT) excl Other Income
21.30
51.70
-58.80%
Interest
3.50
12.10
-71.07%
Exceptional Items
-0.40
2.20
-118.18%
Consolidate Net Profit
14.70
30.50
-51.80%
Operating Profit Margin (Excl OI)
-73.20%
1.40%
-7.46%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 21.45% vs 28.17% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -51.80% vs 1,552.38% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,148.90
894.40
28.45%
Operating Profit (PBDIT) excl Other Income
67.90
-217.50
131.22%
Interest
62.10
65.20
-4.75%
Exceptional Items
-2.80
-6.70
58.21%
Consolidate Net Profit
30.20
-416.00
107.26%
Operating Profit Margin (Excl OI)
-109.60%
-502.20%
39.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 28.45% vs 134.50% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 107.26% vs 80.86% in Dec 2024
About CanSino Biologics, Inc. 
CanSino Biologics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






